Avantor, Inc. (AVTR) |
| 8.18 0.28 (3.54%) 04-13 16:00 |
| Open: | 7.84 |
| High: | 8.21 |
| Low: | 7.82 |
| Volume: | 4,539,266 |
| Market Cap: | 5,579(M) |
| PE Ratio: | -10.49 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 9.97 |
| Resistance 1: | 8.54 |
| Pivot price: | 7.81 |
| Support 1: | 7.75 |
| Support 2: | 7.26 |
| 52w High: | 16.17 |
| 52w Low: | 7.265 |
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
| EPS | -0.780 |
| Book Value | 8.240 |
| PEG Ratio | 0.00 |
| Gross Profit | 3.165 |
| Profit Margin (%) | -8.09 |
| Operating Margin (%) | 10.17 |
| Return on Assets (ttm) | 3.0 |
| Return on Equity (ttm) | -9.2 |
Mon, 13 Apr 2026
Avantor expands St. Louis lab to speed testing for U.S. drugmakers - Stock Titan
Mon, 13 Apr 2026
Avantor® Enhances U.S. Biomanufacturing Infrastructure with Expanded Stability and Microbial Testing Facility - PR Newswire
Mon, 13 Apr 2026
Analysts Hold Neutral Stance on Avantor, Inc. (AVTR) Amid Lower Valuation Expectations - Yahoo Finance
Fri, 10 Apr 2026
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Stockholders to Connect - ACCESS Newswire
Thu, 09 Apr 2026
How Avantor’s (AVTR) CFO Transition Could Shape Its Financial Discipline and Strategic Execution - simplywall.st
Mon, 06 Apr 2026
[Form 4] Avantor, Inc. Insider Trading Activity - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |